Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
Brigham and Women's Hospital · Harvard University · +3 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
768
total citations
- FWCI
- 15.72
- Percentile
- 100%
- References
- 90
Citations per year
Authors
5- KKKeiichi KondoCorresponding
Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center
- JKJeff Klco
Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center
- ENEijiro Nakamura
Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center
- MLMirna Lechpammer
Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center
- WGWilliam G. Kaelin
Brigham and Women's Hospital, Howard Hughes Medical Institute, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center
Topics & keywords
Topics
Keywords
- Cancer research
- Suppressor
- Carcinogenesis
- Transcription factor
- Tumor suppressor gene
- Biology
- Ubiquitin
- Clear cell renal cell carcinoma
No related works found for this paper.